Back

When to Refer for Septal Reduction Therapy

19 March 2026 (09:30 - 10:00)
Organised by: Logo
Seminar Presentation Part of: Level I - Session 2 : Management of HCM Physical Inactivity and Exercise Open Access EAPC Course : Hypertrophic Cardiomyopathy 2026 European Association of Preventive Cardiology (EAPC)

About the speaker

Photo
Professor Maria Teresa Tome Esteban

St George's Healthcare NHS Trust, London (United Kingdom of Great Britain & Northern Ireland)

4 More presentations in this session

Presentation thumbnail
Lifestyle, Exercise & HCM: What’s Safe?
Professor S. Sharma (London, GB)
Slides Video
Presentation thumbnail
Pharmacological Management of HCM
Professor I. Olivotto (Florence, IT)
Slides Video
Presentation thumbnail
Interactive Case Workshop II: Risk Stratification
Professor M. Tome Esteban (London, GB)
Slides Video
Presentation thumbnail
Wrap-Up & Transition to Advanced Course
Doctor G. Finocchiaro (London, GB) Professor M. Pieroni (Florence, IT)
Slides Video

Access the full session

Session thumbnail
Level I - Session 2 : Management of HCM

The Event

Event poster

EAPC Course : Hypertrophic Cardiomyopathy 2026

19 March 2026 09:30 CET
You may be interested in
thumbnail
Congress Presentation
Auditing the safety and efficacy of interventional septal reduction therapies in hypertrophic obstructive cardiomyopathy at a specialized tertiary centre
18 April 2023
thumbnail
Congress Presentation
When and how to do surgery for atrial septal defect.
26 August 2022
thumbnail
Congress Session
How to approach a patient with functional mitral regurgitation
19 May 2025
thumbnail
Congress Session
When to consider device therapy in HFrEF
20 May 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources